MRSA (methicillin-resistant staphylococcus aureus)

MRSA is presently a pathogen of global health concern. . They are S. aureus strains that are resistant to oxacillin, nafcillin and methicillin. They can also be resistant to all ß-lactam agents.  It can cause a variety of problems ranging from skin infections and sepsis to pneumonia and various types of bloodstream infections. The infections occur commonly among people in hospitals and healthcare facilities such as nursing homes, diagnostic centres and dialysis centres, who have less stable immune systems. The current arsenal of antibiotics available for the treatment of MRSA includes a topical agent, a limited number of oral agents.

 

  • Community-acquired MRSA (CA-MRSA)
  • Healthcare-associated MRSA (HA-MRSA)
  • Virulence Associated Factors of CA-MRSA
  • Antibiotic resistance
  • Recurrent MRSA Infections
  • Oral and intravenous agents
  • Topical agents
  • Vancomycin, Clindamycin and linezolid
  • Pneumonia (HAP/VAP)
  • Chronic osteomyelitis (COM)
  • Skin and soft tissue infections

Related Conference of MRSA (methicillin-resistant staphylococcus aureus)

August 28-29, 2025

8th Pathology and Infectious Disease Conference

London, UK
September 22-23, 2025

11th International Conference on Infectious and Rare Diseases

Vancouver, Canada
December 11-12, 2025

8th Annual Congress on Bacterial, Viral and Infectious Diseases

Prague, Czech Republic
December 15-16, 2025

7th Global Experts Meeting on Infectious Diseases

Barcelona, Spain
December 17-18, 2025

17th Global Conference on Nephrology and Infectious Diseases

Amsterdam, Netherlands
May 18-19, 2026

15th World Congress on Rare Diseases and Orphan Drugs

Prague, Czech Republic

MRSA (methicillin-resistant staphylococcus aureus) Conference Speakers

    Recommended Sessions

    Related Journals

    Are you interested in